首页> 外文期刊>Retina >Short-term efficacy of intravitreal aflibercept in treatment-naive patients with polypoidal choroidal vasculopathy.
【24h】

Short-term efficacy of intravitreal aflibercept in treatment-naive patients with polypoidal choroidal vasculopathy.

机译:玻璃体腔注射阿柏西普在初次治疗的多发性脉络膜脉络膜血管病患者中的短期疗效。

获取原文
获取原文并翻译 | 示例
           

摘要

Intravitreal aflibercept was well tolerated and had improved the vision of treatment-naive patients with polypoidal choroidal vasculopathy when it was evaluated at short-term follow-up examinations. Intravitreal aflibercept might be associated with a high possibility of achieving involution of polyps and reducing exudative findings.
机译:在短期随访检查中评估时,玻璃体腔注射阿柏西普具有良好的耐受性,并改善了初治多发性脉络膜脉络膜血管病的患者的视力。玻璃体腔注射阿柏西普可能与息肉的复旧和减少渗出性发现的可能性高有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号